nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabigatran etexilate—ABCB1—Methylprednisolone—ankylosing spondylitis	0.154	0.279	CbGbCtD
Dabigatran etexilate—ABCB1—Betamethasone—ankylosing spondylitis	0.1	0.182	CbGbCtD
Dabigatran etexilate—ABCB1—Prednisolone—ankylosing spondylitis	0.099	0.179	CbGbCtD
Dabigatran etexilate—ABCB1—Prednisone—ankylosing spondylitis	0.0935	0.169	CbGbCtD
Dabigatran etexilate—F2—knee—ankylosing spondylitis	0.0602	0.573	CbGeAlD
Dabigatran etexilate—ABCB1—Dexamethasone—ankylosing spondylitis	0.0584	0.106	CbGbCtD
Dabigatran etexilate—ABCB1—Methotrexate—ankylosing spondylitis	0.0469	0.0849	CbGbCtD
Dabigatran etexilate—F2—vertebral column—ankylosing spondylitis	0.0343	0.327	CbGeAlD
Dabigatran etexilate—CES2—tendon—ankylosing spondylitis	0.00553	0.0527	CbGeAlD
Dabigatran etexilate—NQO2—tendon—ankylosing spondylitis	0.00494	0.0471	CbGeAlD
Dabigatran etexilate—Ecchymosis—Prednisone—ankylosing spondylitis	0.00188	0.00548	CcSEcCtD
Dabigatran etexilate—Hepatic enzyme increased—Methotrexate—ankylosing spondylitis	0.00183	0.00535	CcSEcCtD
Dabigatran etexilate—Cardiac failure—Betamethasone—ankylosing spondylitis	0.00177	0.00518	CcSEcCtD
Dabigatran etexilate—Cardiac failure—Dexamethasone—ankylosing spondylitis	0.00177	0.00518	CcSEcCtD
Dabigatran etexilate—Osteoarthritis—Dexamethasone—ankylosing spondylitis	0.00173	0.00505	CcSEcCtD
Dabigatran etexilate—Osteoarthritis—Betamethasone—ankylosing spondylitis	0.00173	0.00505	CcSEcCtD
Dabigatran etexilate—Alanine aminotransferase increased—Methylprednisolone—ankylosing spondylitis	0.00168	0.0049	CcSEcCtD
Dabigatran etexilate—Cardiac failure congestive—Prednisone—ankylosing spondylitis	0.00166	0.00485	CcSEcCtD
Dabigatran etexilate—Influenza—Triamcinolone—ankylosing spondylitis	0.00165	0.00481	CcSEcCtD
Dabigatran etexilate—Bronchospasm—Methylprednisolone—ankylosing spondylitis	0.00162	0.00472	CcSEcCtD
Dabigatran etexilate—Bronchitis—Triamcinolone—ankylosing spondylitis	0.00158	0.00463	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Prednisolone—ankylosing spondylitis	0.00157	0.0046	CcSEcCtD
Dabigatran etexilate—Ecchymosis—Methotrexate—ankylosing spondylitis	0.00157	0.00458	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Prednisolone—ankylosing spondylitis	0.00157	0.00457	CcSEcCtD
Dabigatran etexilate—Cardiac failure—Prednisone—ankylosing spondylitis	0.00154	0.00451	CcSEcCtD
Dabigatran etexilate—Upper respiratory tract infection—Triamcinolone—ankylosing spondylitis	0.00153	0.00447	CcSEcCtD
Dabigatran etexilate—Osteoarthritis—Prednisone—ankylosing spondylitis	0.00151	0.0044	CcSEcCtD
Dabigatran etexilate—Gastrointestinal haemorrhage—Prednisone—ankylosing spondylitis	0.00151	0.0044	CcSEcCtD
Dabigatran etexilate—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.00147	0.00428	CcSEcCtD
Dabigatran etexilate—Infestation—Methylprednisolone—ankylosing spondylitis	0.00147	0.00428	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Triamcinolone—ankylosing spondylitis	0.00145	0.00423	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Methylprednisolone—ankylosing spondylitis	0.00144	0.00422	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Prednisolone—ankylosing spondylitis	0.00144	0.00421	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Triamcinolone—ankylosing spondylitis	0.00144	0.0042	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Methylprednisolone—ankylosing spondylitis	0.00144	0.0042	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Prednisolone—ankylosing spondylitis	0.00143	0.00419	CcSEcCtD
Dabigatran etexilate—Epistaxis—Triamcinolone—ankylosing spondylitis	0.00139	0.00405	CcSEcCtD
Dabigatran etexilate—Alanine aminotransferase increased—Prednisone—ankylosing spondylitis	0.00133	0.00388	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.00133	0.00387	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.00132	0.00386	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.00132	0.00385	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.00132	0.00384	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Dexamethasone—ankylosing spondylitis	0.00131	0.00384	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Betamethasone—ankylosing spondylitis	0.00131	0.00384	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.00131	0.00382	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.00131	0.00382	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.00129	0.00378	CcSEcCtD
Dabigatran etexilate—Osteoarthritis—Methotrexate—ankylosing spondylitis	0.00126	0.00368	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00122	0.00357	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.0012	0.00351	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Betamethasone—ankylosing spondylitis	0.0012	0.00351	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.0012	0.00349	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Betamethasone—ankylosing spondylitis	0.0012	0.00349	CcSEcCtD
Dabigatran etexilate—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.00119	0.00349	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.00119	0.00347	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00119	0.00346	CcSEcCtD
Dabigatran etexilate—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.00116	0.00339	CcSEcCtD
Dabigatran etexilate—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00115	0.00334	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.00114	0.00334	CcSEcCtD
Dabigatran etexilate—Angioedema—Prednisolone—ankylosing spondylitis	0.00114	0.00333	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Prednisone—ankylosing spondylitis	0.00114	0.00332	CcSEcCtD
Dabigatran etexilate—Syncope—Prednisolone—ankylosing spondylitis	0.00112	0.00327	CcSEcCtD
Dabigatran etexilate—Back pain—Triamcinolone—ankylosing spondylitis	0.00111	0.00324	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.0011	0.0032	CcSEcCtD
Dabigatran etexilate—Angiopathy—Betamethasone—ankylosing spondylitis	0.00109	0.00317	CcSEcCtD
Dabigatran etexilate—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00109	0.00317	CcSEcCtD
Dabigatran etexilate—Hypertension—Prednisolone—ankylosing spondylitis	0.00108	0.00315	CcSEcCtD
Dabigatran etexilate—Angioedema—Triamcinolone—ankylosing spondylitis	0.00105	0.00306	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Prednisone—ankylosing spondylitis	0.00105	0.00306	CcSEcCtD
Dabigatran etexilate—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00105	0.00306	CcSEcCtD
Dabigatran etexilate—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.00104	0.00305	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Prednisone—ankylosing spondylitis	0.00104	0.00304	CcSEcCtD
Dabigatran etexilate—Syncope—Triamcinolone—ankylosing spondylitis	0.00103	0.00301	CcSEcCtD
Dabigatran etexilate—Syncope—Methylprednisolone—ankylosing spondylitis	0.00103	0.003	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00102	0.00299	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00102	0.00298	CcSEcCtD
Dabigatran etexilate—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.00101	0.00295	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00101	0.00295	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00101	0.00294	CcSEcCtD
Dabigatran etexilate—Shock—Prednisolone—ankylosing spondylitis	0.001	0.00293	CcSEcCtD
Dabigatran etexilate—Cough—Triamcinolone—ankylosing spondylitis	0.001	0.00293	CcSEcCtD
Dabigatran etexilate—Hypertension—Triamcinolone—ankylosing spondylitis	0.000991	0.00289	CcSEcCtD
Dabigatran etexilate—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000989	0.00289	CcSEcCtD
Dabigatran etexilate—Pneumonia—Methotrexate—ankylosing spondylitis	0.000976	0.00285	CcSEcCtD
Dabigatran etexilate—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000975	0.00285	CcSEcCtD
Dabigatran etexilate—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00097	0.00283	CcSEcCtD
Dabigatran etexilate—Infestation—Methotrexate—ankylosing spondylitis	0.00097	0.00283	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000968	0.00283	CcSEcCtD
Dabigatran etexilate—Angioedema—Dexamethasone—ankylosing spondylitis	0.000952	0.00278	CcSEcCtD
Dabigatran etexilate—Angioedema—Betamethasone—ankylosing spondylitis	0.000952	0.00278	CcSEcCtD
Dabigatran etexilate—Angiopathy—Prednisone—ankylosing spondylitis	0.000945	0.00276	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Prednisone—ankylosing spondylitis	0.000941	0.00275	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000937	0.00274	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000935	0.00273	CcSEcCtD
Dabigatran etexilate—Syncope—Dexamethasone—ankylosing spondylitis	0.000934	0.00273	CcSEcCtD
Dabigatran etexilate—Syncope—Betamethasone—ankylosing spondylitis	0.000934	0.00273	CcSEcCtD
Dabigatran etexilate—Infection—Triamcinolone—ankylosing spondylitis	0.000931	0.00272	CcSEcCtD
Dabigatran etexilate—Infection—Methylprednisolone—ankylosing spondylitis	0.000929	0.00271	CcSEcCtD
Dabigatran etexilate—Haematuria—Methotrexate—ankylosing spondylitis	0.000925	0.0027	CcSEcCtD
Dabigatran etexilate—Shock—Triamcinolone—ankylosing spondylitis	0.000922	0.00269	CcSEcCtD
Dabigatran etexilate—Shock—Methylprednisolone—ankylosing spondylitis	0.00092	0.00269	CcSEcCtD
Dabigatran etexilate—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000917	0.00268	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000917	0.00268	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000915	0.00267	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000915	0.00267	CcSEcCtD
Dabigatran etexilate—Epistaxis—Methotrexate—ankylosing spondylitis	0.000915	0.00267	CcSEcCtD
Dabigatran etexilate—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000908	0.00265	CcSEcCtD
Dabigatran etexilate—Malnutrition—Prednisone—ankylosing spondylitis	0.000907	0.00265	CcSEcCtD
Dabigatran etexilate—Hypertension—Betamethasone—ankylosing spondylitis	0.000899	0.00263	CcSEcCtD
Dabigatran etexilate—Hypertension—Dexamethasone—ankylosing spondylitis	0.000899	0.00263	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000875	0.00256	CcSEcCtD
Dabigatran etexilate—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000873	0.00255	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000871	0.00254	CcSEcCtD
Dabigatran etexilate—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00086	0.00251	CcSEcCtD
Dabigatran etexilate—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000854	0.00249	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000853	0.00249	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000852	0.00249	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00085	0.00248	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00085	0.00248	CcSEcCtD
Dabigatran etexilate—Infection—Dexamethasone—ankylosing spondylitis	0.000844	0.00247	CcSEcCtD
Dabigatran etexilate—Infection—Betamethasone—ankylosing spondylitis	0.000844	0.00247	CcSEcCtD
Dabigatran etexilate—Anaemia—Prednisone—ankylosing spondylitis	0.000838	0.00245	CcSEcCtD
Dabigatran etexilate—Shock—Betamethasone—ankylosing spondylitis	0.000836	0.00244	CcSEcCtD
Dabigatran etexilate—Shock—Dexamethasone—ankylosing spondylitis	0.000836	0.00244	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000835	0.00244	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000834	0.00243	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000834	0.00243	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000832	0.00243	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000832	0.00243	CcSEcCtD
Dabigatran etexilate—Angioedema—Prednisone—ankylosing spondylitis	0.000829	0.00242	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000825	0.00241	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000823	0.0024	CcSEcCtD
Dabigatran etexilate—Syncope—Prednisone—ankylosing spondylitis	0.000813	0.00238	CcSEcCtD
Dabigatran etexilate—Urticaria—Prednisolone—ankylosing spondylitis	0.000809	0.00236	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000808	0.00236	CcSEcCtD
Dabigatran etexilate—Fatigue—Triamcinolone—ankylosing spondylitis	0.000808	0.00236	CcSEcCtD
Dabigatran etexilate—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000806	0.00235	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000797	0.00233	CcSEcCtD
Dabigatran etexilate—Hypotension—Dexamethasone—ankylosing spondylitis	0.000794	0.00232	CcSEcCtD
Dabigatran etexilate—Hypotension—Betamethasone—ankylosing spondylitis	0.000794	0.00232	CcSEcCtD
Dabigatran etexilate—Angiopathy—Methotrexate—ankylosing spondylitis	0.00079	0.00231	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000786	0.0023	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000785	0.00229	CcSEcCtD
Dabigatran etexilate—Hypertension—Prednisone—ankylosing spondylitis	0.000783	0.00229	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000774	0.00226	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000774	0.00226	CcSEcCtD
Dabigatran etexilate—Arthralgia—Prednisone—ankylosing spondylitis	0.000772	0.00226	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000767	0.00224	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000764	0.00223	CcSEcCtD
Dabigatran etexilate—Malnutrition—Methotrexate—ankylosing spondylitis	0.000758	0.00221	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00075	0.00219	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000748	0.00219	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000748	0.00219	CcSEcCtD
Dabigatran etexilate—Urticaria—Triamcinolone—ankylosing spondylitis	0.000744	0.00217	CcSEcCtD
Dabigatran etexilate—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000743	0.00217	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00074	0.00216	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000739	0.00216	CcSEcCtD
Dabigatran etexilate—Infection—Prednisone—ankylosing spondylitis	0.000735	0.00215	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000734	0.00214	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000734	0.00214	CcSEcCtD
Dabigatran etexilate—Back pain—Methotrexate—ankylosing spondylitis	0.000733	0.00214	CcSEcCtD
Dabigatran etexilate—Fatigue—Dexamethasone—ankylosing spondylitis	0.000733	0.00214	CcSEcCtD
Dabigatran etexilate—Fatigue—Betamethasone—ankylosing spondylitis	0.000733	0.00214	CcSEcCtD
Dabigatran etexilate—Shock—Prednisone—ankylosing spondylitis	0.000728	0.00213	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000726	0.00212	CcSEcCtD
Dabigatran etexilate—Skin disorder—Prednisone—ankylosing spondylitis	0.000719	0.0021	CcSEcCtD
Dabigatran etexilate—Anaemia—Methotrexate—ankylosing spondylitis	0.000701	0.00205	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000695	0.00203	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000695	0.00203	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00069	0.00202	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000689	0.00201	CcSEcCtD
Dabigatran etexilate—Urticaria—Dexamethasone—ankylosing spondylitis	0.000675	0.00197	CcSEcCtD
Dabigatran etexilate—Urticaria—Betamethasone—ankylosing spondylitis	0.000675	0.00197	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000674	0.00197	CcSEcCtD
Dabigatran etexilate—Dizziness—Prednisolone—ankylosing spondylitis	0.000674	0.00197	CcSEcCtD
Dabigatran etexilate—Asthenia—Triamcinolone—ankylosing spondylitis	0.000672	0.00196	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000672	0.00196	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000672	0.00196	CcSEcCtD
Dabigatran etexilate—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000671	0.00196	CcSEcCtD
Dabigatran etexilate—Pruritus—Triamcinolone—ankylosing spondylitis	0.000663	0.00194	CcSEcCtD
Dabigatran etexilate—Cough—Methotrexate—ankylosing spondylitis	0.000661	0.00193	CcSEcCtD
Dabigatran etexilate—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000661	0.00193	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Prednisone—ankylosing spondylitis	0.000652	0.0019	CcSEcCtD
Dabigatran etexilate—Arthralgia—Methotrexate—ankylosing spondylitis	0.000645	0.00188	CcSEcCtD
Dabigatran etexilate—Chest pain—Methotrexate—ankylosing spondylitis	0.000645	0.00188	CcSEcCtD
Dabigatran etexilate—Rash—Prednisolone—ankylosing spondylitis	0.000642	0.00188	CcSEcCtD
Dabigatran etexilate—Dermatitis—Prednisolone—ankylosing spondylitis	0.000642	0.00187	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000641	0.00187	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00064	0.00187	CcSEcCtD
Dabigatran etexilate—Fatigue—Prednisone—ankylosing spondylitis	0.000638	0.00186	CcSEcCtD
Dabigatran etexilate—Headache—Prednisolone—ankylosing spondylitis	0.000638	0.00186	CcSEcCtD
Dabigatran etexilate—Constipation—Prednisone—ankylosing spondylitis	0.000633	0.00185	CcSEcCtD
Dabigatran etexilate—Dizziness—Triamcinolone—ankylosing spondylitis	0.000619	0.00181	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000619	0.00181	CcSEcCtD
Dabigatran etexilate—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000618	0.00181	CcSEcCtD
Dabigatran etexilate—Infection—Methotrexate—ankylosing spondylitis	0.000615	0.00179	CcSEcCtD
Dabigatran etexilate—Asthenia—Betamethasone—ankylosing spondylitis	0.00061	0.00178	CcSEcCtD
Dabigatran etexilate—Asthenia—Dexamethasone—ankylosing spondylitis	0.00061	0.00178	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000607	0.00177	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000606	0.00177	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000605	0.00177	CcSEcCtD
Dabigatran etexilate—Nausea—Prednisolone—ankylosing spondylitis	0.000605	0.00177	CcSEcCtD
Dabigatran etexilate—Pruritus—Betamethasone—ankylosing spondylitis	0.000601	0.00176	CcSEcCtD
Dabigatran etexilate—Pruritus—Dexamethasone—ankylosing spondylitis	0.000601	0.00176	CcSEcCtD
Dabigatran etexilate—Skin disorder—Methotrexate—ankylosing spondylitis	0.000601	0.00175	CcSEcCtD
Dabigatran etexilate—Vomiting—Triamcinolone—ankylosing spondylitis	0.000596	0.00174	CcSEcCtD
Dabigatran etexilate—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000594	0.00174	CcSEcCtD
Dabigatran etexilate—Rash—Triamcinolone—ankylosing spondylitis	0.000591	0.00173	CcSEcCtD
Dabigatran etexilate—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00059	0.00172	CcSEcCtD
Dabigatran etexilate—Rash—Methylprednisolone—ankylosing spondylitis	0.000589	0.00172	CcSEcCtD
Dabigatran etexilate—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000589	0.00172	CcSEcCtD
Dabigatran etexilate—Urticaria—Prednisone—ankylosing spondylitis	0.000588	0.00172	CcSEcCtD
Dabigatran etexilate—Headache—Triamcinolone—ankylosing spondylitis	0.000587	0.00171	CcSEcCtD
Dabigatran etexilate—Headache—Methylprednisolone—ankylosing spondylitis	0.000586	0.00171	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Prednisone—ankylosing spondylitis	0.000585	0.00171	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000582	0.0017	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000582	0.0017	CcSEcCtD
Dabigatran etexilate—Hypotension—Methotrexate—ankylosing spondylitis	0.000578	0.00169	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000564	0.00165	CcSEcCtD
Dabigatran etexilate—Dizziness—Dexamethasone—ankylosing spondylitis	0.000562	0.00164	CcSEcCtD
Dabigatran etexilate—Dizziness—Betamethasone—ankylosing spondylitis	0.000562	0.00164	CcSEcCtD
Dabigatran etexilate—Nausea—Triamcinolone—ankylosing spondylitis	0.000556	0.00163	CcSEcCtD
Dabigatran etexilate—Nausea—Methylprednisolone—ankylosing spondylitis	0.000555	0.00162	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000552	0.00161	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000545	0.00159	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000545	0.00159	CcSEcCtD
Dabigatran etexilate—Vomiting—Dexamethasone—ankylosing spondylitis	0.00054	0.00158	CcSEcCtD
Dabigatran etexilate—Vomiting—Betamethasone—ankylosing spondylitis	0.00054	0.00158	CcSEcCtD
Dabigatran etexilate—Rash—Betamethasone—ankylosing spondylitis	0.000536	0.00157	CcSEcCtD
Dabigatran etexilate—Rash—Dexamethasone—ankylosing spondylitis	0.000536	0.00157	CcSEcCtD
Dabigatran etexilate—Dermatitis—Betamethasone—ankylosing spondylitis	0.000535	0.00156	CcSEcCtD
Dabigatran etexilate—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000535	0.00156	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000534	0.00156	CcSEcCtD
Dabigatran etexilate—Fatigue—Methotrexate—ankylosing spondylitis	0.000533	0.00156	CcSEcCtD
Dabigatran etexilate—Headache—Dexamethasone—ankylosing spondylitis	0.000532	0.00156	CcSEcCtD
Dabigatran etexilate—Headache—Betamethasone—ankylosing spondylitis	0.000532	0.00156	CcSEcCtD
Dabigatran etexilate—Asthenia—Prednisone—ankylosing spondylitis	0.000531	0.00155	CcSEcCtD
Dabigatran etexilate—Pruritus—Prednisone—ankylosing spondylitis	0.000524	0.00153	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Prednisone—ankylosing spondylitis	0.000506	0.00148	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000506	0.00148	CcSEcCtD
Dabigatran etexilate—Nausea—Betamethasone—ankylosing spondylitis	0.000505	0.00147	CcSEcCtD
Dabigatran etexilate—Nausea—Dexamethasone—ankylosing spondylitis	0.000505	0.00147	CcSEcCtD
Dabigatran etexilate—Urticaria—Methotrexate—ankylosing spondylitis	0.000491	0.00144	CcSEcCtD
Dabigatran etexilate—Dizziness—Prednisone—ankylosing spondylitis	0.000489	0.00143	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000489	0.00143	CcSEcCtD
Dabigatran etexilate—Vomiting—Prednisone—ankylosing spondylitis	0.000471	0.00137	CcSEcCtD
Dabigatran etexilate—Rash—Prednisone—ankylosing spondylitis	0.000467	0.00136	CcSEcCtD
Dabigatran etexilate—Dermatitis—Prednisone—ankylosing spondylitis	0.000466	0.00136	CcSEcCtD
Dabigatran etexilate—Headache—Prednisone—ankylosing spondylitis	0.000464	0.00135	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000456	0.00133	CcSEcCtD
Dabigatran etexilate—Asthenia—Methotrexate—ankylosing spondylitis	0.000444	0.0013	CcSEcCtD
Dabigatran etexilate—Nausea—Prednisone—ankylosing spondylitis	0.00044	0.00128	CcSEcCtD
Dabigatran etexilate—Pruritus—Methotrexate—ankylosing spondylitis	0.000438	0.00128	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000423	0.00124	CcSEcCtD
Dabigatran etexilate—Dizziness—Methotrexate—ankylosing spondylitis	0.000409	0.00119	CcSEcCtD
Dabigatran etexilate—Vomiting—Methotrexate—ankylosing spondylitis	0.000393	0.00115	CcSEcCtD
Dabigatran etexilate—Rash—Methotrexate—ankylosing spondylitis	0.00039	0.00114	CcSEcCtD
Dabigatran etexilate—Dermatitis—Methotrexate—ankylosing spondylitis	0.00039	0.00114	CcSEcCtD
Dabigatran etexilate—Headache—Methotrexate—ankylosing spondylitis	0.000388	0.00113	CcSEcCtD
Dabigatran etexilate—Nausea—Methotrexate—ankylosing spondylitis	0.000367	0.00107	CcSEcCtD
